Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Navelbine 10mg/1ml concentrate for inf vials
0801040R0BBAAAA
|
Navelbine | Vinorelbine | Malignant Disease and Immunosuppression | No data available |
|
Navelbine 20mg capsules
0801040R0BBACAC
|
Navelbine | Vinorelbine | Malignant Disease and Immunosuppression | No data available |
|
Navelbine 30mg capsules
0801040R0BBADAD
|
Navelbine | Vinorelbine | Malignant Disease and Immunosuppression | No data available |
|
Navelbine 50mg/5ml concentrate for inf vials
0801040R0BBABAB
|
Navelbine | Vinorelbine | Malignant Disease and Immunosuppression | No data available |
|
Navelbine 80mg capsules
0801040R0BBAEAE
|
Navelbine | Vinorelbine | Malignant Disease and Immunosuppression | No data available |
|
Vinorelbine 10mg/1ml solution for infusion vials
0801040R0AAAAAA
|
Vinorelbine | Vinorelbine | Malignant Disease and Immunosuppression | No data available |
|
Vinorelbine 20mg capsules
0801040R0AAACAC
|
Vinorelbine | Vinorelbine | Malignant Disease and Immunosuppression | No data available |
|
Vinorelbine 30mg capsules
0801040R0AAADAD
|
Vinorelbine | Vinorelbine | Malignant Disease and Immunosuppression | No data available |
|
Vinorelbine 50mg/5ml solution for infusion vials
0801040R0AAABAB
|
Vinorelbine | Vinorelbine | Malignant Disease and Immunosuppression | No data available |
|
Vinorelbine 80mg capsules
0801040R0AAAEAE
|
Vinorelbine | Vinorelbine | Malignant Disease and Immunosuppression | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.